MYDA Advisors’s TriSalus Life Sciences TLSI Stock Holding History

MYDA Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-270,000	Closed	-$2.68M	–	128
2022 Q3	$2.68M	Hold	270,000	–	–	1.26%	23
2022 Q2	$2.66M	Sell	270,000 -30,000	-10%	-$295K	0.74%	30
2022 Q1	$2.94M	Sell	300,000 -103,070	-26%	-$1.02M	1.16%	22
2021 Q4	$3.98M	Hold	403,070	–	–	1.06%	24
2021 Q3	$4M	Hold	403,070	–	–	1.12%	22
2021 Q2	$3.91M	Buy	403,070 +200,000	+98%	+$1.96M	0.97%	21
2021 Q1	$1.96M	Buy	+203,070	New	+$2.06M	0.54%	62

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MYDA Advisors's TLSI Position: Q4 2022 in Review

MYDA Advisors sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 270,000 shares — an estimated $2.68M sold.

MYDA Advisors first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $4M in Q3 2021. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

MYDA Advisors reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
MYDA Advisors sold 270,000 TriSalus Life Sciences shares in Q4 2022, an estimated $2.68M.
MYDA Advisors first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
MYDA Advisors's TriSalus Life Sciences position peaked at $4M in Q3 2021.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on MYDA Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.